National Health (Listed drugs on F1 or F2) Amendment Determination 2015 (No. 2) (PB 15 of 2015)

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now for only USD$20 per month, or Get a Day Pass for only USD$4.99.
 
PB 15 of 2015
 
National Health (Listed drugs on F1 or F2) Amendment Determination 2015 (No. 2)
National Health Act 1953
I, ADRIANA PLATONA, Assistant Secretary , Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 85AB(1) of the National Health Act 1953.
Dated             24            February 2015
 
 
 
 
 
 
 
 
 
ADRIANA PLATONA
 
Assistant Secretary
Pharmaceutical Evaluation Branch
Pharmaceutical Benefits Division
Department of Health
 
 
 
 
Part 1         Preliminary
1              Name of Determination
         (1)   This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2015 (No. 2).
         (2)   This Determination may also be cited as PB 15 of 2015.
2              Commencement
                This Determination commences on 1 March 2015.
3              Amendment of National Health (Listed drugs on F1 or F2) Determination 2010
                Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).
Schedule 1             Amendments
 
(Section 3)
 
 
[1]     Schedule 1, after item dealing with Clostridium botulinum toxin type A toxin-haemagglutinin complex
 
Insert
 
Coal tar
 
[2]     Schedule 1, after item dealing with Peginterferon alfa-2a
 
Insert
 
Peginterferon Beta-1a
 
 
[3]     Schedule 1, after item dealing with Phenytoin
 
Insert
 
Phytomenadione
 
 
 
 
 
 
 
 
 
 
 
 

Related Laws